| P50 | author | Diana Karpman | Q42887742 |
| | Johan Rebetz | Q56589967 |
| P2093 | author name string | Ludger Johannes | |
| | Ann-Charlotte Kristoffersson | |
| | Anne-Lie Ståhl | |
| | Ida Arvidsson | |
| | Milan Chromek | |
| | Ashmita Tontanahal | |
| | Sebastian Loos | |
| | Karl E Johansson | |
| P2860 | cites work | Crystal structure of the holotoxino from Shigella dysenteriae at 2.5 Å resolution | Q27729840 |
| | Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model | Q28487975 |
| | Haemolytic uraemic syndrome | Q30244707 |
| | Rapid Apoptosis Induced by Shiga Toxin in HeLa Cells | Q30310781 |
| | Shiga toxin binds to activated platelets | Q30312261 |
| | NF449, a novel picomolar potency antagonist at human P2X1 receptors | Q30320633 |
| | Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. | Q30439707 |
| | Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome | Q33386199 |
| | Intestinal damage in enterohemorrhagic Escherichia coli infection. | Q33391718 |
| | Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome | Q33394691 |
| | The antimicrobial peptide cathelicidin protects mice from Escherichia coli O157:H7-mediated disease. | Q33403877 |
| | Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome | Q33420087 |
| | Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response | Q33423835 |
| | Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies | Q33501527 |
| | Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. | Q34049372 |
| | Shiga toxin binding to glycolipids and glycans | Q34163196 |
| | Membrane microparticles: two sides of the coin | Q34384910 |
| | The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes | Q34465406 |
| | Shiga toxin induces tubular membrane invaginations for its uptake into cells | Q34719609 |
| | Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model | Q35075768 |
| | Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP. | Q35092822 |
| | Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis. | Q35125120 |
| | A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles | Q35125841 |
| | Signal transduction pathways to apoptosis | Q35632911 |
| | Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease | Q36519690 |
| | Shiga and Shiga-like toxins | Q37063416 |
| | Calcium signaling in platelets | Q37473529 |
| | Cellular mechanisms underlying the formation of circulating microparticles | Q37821168 |
| | Roles of exosomes and microvesicles in disease pathogenesis | Q38043783 |
| | Medicinal chemistry of P2X receptors: agonists and orthosteric antagonists. | Q38290903 |
| | Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli | Q38751619 |
| | Recent Updates on Development of Drug Molecules for Human African Trypanosomiasis | Q38806890 |
| | Calcium Signalling through Ligand-Gated Ion Channels such as P2X1 Receptors in the Platelet and other Non-Excitable Cells. | Q38830299 |
| | Cross-linking of glycosphingolipids at the plasma membrane: consequences for intracellular signaling and traffic | Q38832453 |
| | Purinergic signaling in kidney disease | Q38990634 |
| | Investigating endocytic pathways to the endoplasmic reticulum and to the cytosol using SNAP-trap | Q39263792 |
| | Extracellular vesicles in renal disease | Q39453434 |
| | Shiga toxin 1 induces apoptosis through the endoplasmic reticulum stress response in human monocytic cells | Q40051377 |
| | P2-purinergic receptors: subtype-associated signaling responses and structure | Q40436997 |
| | Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist | Q40568678 |
| | Ribosome-inactivating protein and apoptosis: abrin causes cell death via mitochondrial pathway in Jurkat cells | Q40634325 |
| | Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin | Q41169583 |
| | Plant Ribosome-Inactivating Proteins: Progesses, Challenges and Biotechnological Applications (and a Few Digressions). | Q41918293 |
| | Platelet Ca(2+) responses coupled to glycoprotein VI and Toll-like receptors persist in the presence of endothelial-derived inhibitors: roles for secondary activation of P2X1 receptors and release from intracellular Ca(2+) stores | Q42326717 |
| | The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis | Q42856082 |
| | Actin dynamics drive membrane reorganization and scission in clathrin-independent endocytosis | Q43152766 |
| | Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist | Q45274145 |
| | Exosomes and microvesicles in normal physiology, pathophysiology, and renal diseases. | Q48225900 |
| | P2X receptor ligands and pain | Q48460330 |
| | Furin-induced cleavage and activation of Shiga toxin | Q49165095 |
| | Roles of Shiga Toxins in Immunopathology. | Q64992859 |
| | Calcium influx is a determining factor of calpain activation and microparticle formation in platelets | Q71447635 |
| | Dependence of depurination of oligoribonucleotides by ricin A-chain on divalent cations and chelating agents | Q71516532 |
| P433 | issue | 1 | |
| P304 | page(s) | 14362 | |
| P577 | publication date | 2019-10-07 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism | |
| P478 | volume | 9 | |